China NT Pharma Group Company Limited

SEHK:2965 Stock Report

Market Cap: HK$68.7m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

China NT Pharma Group Management

Management criteria checks 3/4

China NT Pharma Group's CEO is David Ng, appointed in Jan 1995, has a tenure of 29.58 years. total yearly compensation is CN¥1.67M, comprised of 99% salary and 1% bonuses, including company stock and options. directly owns 0.009% of the company’s shares, worth HK$6.50K. The average tenure of the management team and the board of directors is 2.7 years and 7.2 years respectively.

Key information

David Ng

Chief executive officer

CN¥1.7m

Total compensation

CEO salary percentage99.0%
CEO tenure29.6yrs
CEO ownership0.009%
Management average tenure2.7yrs
Board average tenure7.2yrs

Recent management updates

No updates

Recent updates

No updates

CEO Compensation Analysis

How has David Ng's remuneration changed compared to China NT Pharma Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023CN¥2mCN¥2m

-CN¥33m

Jun 30 2023n/an/a

-CN¥44m

Mar 31 2023n/an/a

-CN¥55m

Dec 31 2022CN¥2mCN¥2m

-CN¥50m

Sep 30 2022n/an/a

-CN¥121m

Jun 30 2022n/an/a

-CN¥175m

Mar 31 2022n/an/a

-CN¥162m

Dec 31 2021CN¥2mCN¥1m

-CN¥150m

Sep 30 2021n/an/a

-CN¥147m

Jun 30 2021n/an/a

-CN¥145m

Mar 31 2021n/an/a

-CN¥167m

Dec 31 2020CN¥2mCN¥2m

-CN¥189m

Sep 30 2020n/an/a

-CN¥271m

Jun 30 2020n/an/a

-CN¥353m

Mar 31 2020n/an/a

-CN¥351m

Dec 31 2019CN¥6mCN¥6m

-CN¥350m

Sep 30 2019n/an/a

-CN¥547m

Jun 30 2019n/an/a

-CN¥744m

Mar 31 2019n/an/a

-CN¥670m

Dec 31 2018CN¥9mCN¥6m

-CN¥596m

Sep 30 2018n/an/a

-CN¥190m

Jun 30 2018n/an/a

CN¥216m

Mar 31 2018n/an/a

CN¥215m

Dec 31 2017CN¥8mCN¥6m

CN¥214m

Compensation vs Market: David's total compensation ($USD232.93K) is about average for companies of similar size in the Hong Kong market ($USD235.36K).

Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.

CEO

David Ng (60 yo)

29.6yrs

Tenure

CN¥1,669,000

Compensation

Mr. Tit Ng, also known as David, has been the Chief Executive Officer and Chairman of China NT Pharma Group Company Limited since 1995. He is a Co-Founder of NT Pharma Group Company Limited. Mr. Ng was app...

Leadership Team

NamePositionTenureCompensationOwnership
Tit Ng
Co-Founder29.6yrsCN¥1.67m0.0095%
HK$ 6.5k
Jing Fang
Chief Financial Officer4.8yrsno datano data
Ching Mei Ng
Executive Directorless than a yearno datano data
Cheung Cheng
Company Secretaryless than a yearno datano data

2.7yrs

Average Tenure

44yo

Average Age

Experienced Management: 2965's management team is considered experienced (2.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Tit Ng
Co-Founder29.6yrsCN¥1.67m0.0095%
HK$ 6.5k
Ching Mei Ng
Executive Directorless than a yearno datano data
Yu Chin
Non-Executive Director14.4yrsCN¥138.00k0.0095%
HK$ 6.5k
Wei Qian
Non-Executive Director14.4yrsno datano data
Tze Shan Yu
Independent Non-Executive Director7.2yrsCN¥138.00k0.0057%
HK$ 3.9k
Ming Kwan Ng
Independent Non-Executive Director1.6yrsCN¥138.00kno data
Yubiao Zhao
Independent Non-Executive Director4.7yrsCN¥138.00kno data

7.2yrs

Average Tenure

60yo

Average Age

Experienced Board: 2965's board of directors are considered experienced (7.2 years average tenure).